A multiple-ascending-dose study to evaluate safety, pharmacokinetics, and pharmacodynamics of a novel GPR40 agonist, TAK-875, in subjects with type 2 diabetes (Q44841100)
Jump to navigation
Jump to search
scientific article published on 6 June 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A multiple-ascending-dose study to evaluate safety, pharmacokinetics, and pharmacodynamics of a novel GPR40 agonist, TAK-875, in subjects with type 2 diabetes |
scientific article published on 6 June 2012 |
Statements
1 reference
A multiple-ascending-dose study to evaluate safety, pharmacokinetics, and pharmacodynamics of a novel GPR40 agonist, TAK-875, in subjects with type 2 diabetes (English)
1 reference
E Leifke
1 reference
H Naik
1 reference
J Wu
1 reference
P Viswanathan
1 reference
D Demanno
1 reference
M Kipnes
1 reference
M Vakilynejad
1 reference
6 June 2012
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference